SCHEMBL19082320

SCHEMBL19082320

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5sc6cc7sc8ccc9ccccc9c8c7cc6c5c4)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.33
NQO1 P15559 1/20 0.33
CHEK1 O14757 1/20 0.32
WEE1 P30291 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CDK4 P11802 1/20 0.31
CCND1 P24385 1/20 0.31
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
CYP1A1 P04798 2/20 0.30
CYP1A2 P05177 1/20 0.30
FYN P06241 1/20 0.30
MAPK3 P27361 1/20 0.30
AHR P35869 1/20 0.30
PAX8 Q06710 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17932047 0.95 NQO2 (0.35) NQO2NQO1CHEK1WEE1KDM4E
SCHEMBL19082326 0.94 NQO2 (0.32) NQO2NQO1KDM4EMEN1KMT2A
SCHEMBL19082090 0.91 NQO2 (0.36) NQO2NQO1CHEK1WEE1KDM4E
SCHEMBL19082323 0.91 NQO2 (0.33) NQO2NQO1CHEK1WEE1KDM4E
SCHEMBL19082316 0.91 CYP1A1 (0.35) NQO2NQO1CHEK1WEE1KDM4E
SCHEMBL17945306 0.90 CHEK1 (0.37) NQO2NQO1CHEK1WEE1KDM4E
SCHEMBL19082143 0.90 CDK4 (0.36) NQO2NQO1CHEK1WEE1KDM4E
SCHEMBL19082209 0.90 CDK4 (0.39) NQO2NQO1CHEK1WEE1CDK4
SCHEMBL19082184 0.89 KDM4E (0.33) NQO2NQO1CHEK1WEE1KDM4E
SCHEMBL17932034 0.89 NQO2 (0.35) NQO2NQO1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885CHEK1 255/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885CHEK1 255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.